Atlas Trials

Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients

Clinical trial NCT01580748 · UNKNOWN

Trial details

NCT number
NCT01580748
Sponsor
Seoul National University Bundang Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Symptomatic Bronchiectasis
Start date
2012-05-01
Primary completion
2012-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.